This document is an excerpt from the EUR-Lex website
Document 62019TN0883
Case T-883/19: Action brought on 27 December 2019 – Gustopharma Consumer Health v EUIPO – Helixor Heilmittel (HELIX ELIXIR)
Case T-883/19: Action brought on 27 December 2019 – Gustopharma Consumer Health v EUIPO – Helixor Heilmittel (HELIX ELIXIR)
Case T-883/19: Action brought on 27 December 2019 – Gustopharma Consumer Health v EUIPO – Helixor Heilmittel (HELIX ELIXIR)
IO C 68, 2.3.2020, p. 51–52
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
2.3.2020 |
EN |
Official Journal of the European Union |
C 68/51 |
Action brought on 27 December 2019 – Gustopharma Consumer Health v EUIPO – Helixor Heilmittel (HELIX ELIXIR)
(Case T-883/19)
(2020/C 68/60)
Language of the case: English
Parties
Applicant: Gustopharma Consumer Health, SL (Madrid, Spain) (represented by: A. Gómez López, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Helixor Heilmittel GmbH (Rosenfeld, Germany)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union trade mark HELIX ELIXIR – Application for registration No 15 035 991
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 23 October 2019 in Case R 100/2019-1
Form of order sought
The applicant claims that the Court should:
|
— |
allow the present Appeal; |
|
— |
annul the contested decision; and/or |
|
— |
set aside the contested decision due to erroneous application of Article 8(1)(b) and enter a finding to the effect that there does not exist likelihood of confusion between the confronted trademarks; |
|
— |
issue a new Resolution granting EUTM Application No 15 035 991 HELIX ELIXIR for all the applied goods; and |
|
— |
order EUIPO (and Intervener, if he enters an appearance in proceedings) to pay the costs. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council |